Electroporation therapy of head and neck cancer

Annals of Otology, Rhinology and Laryngology

Volumn 107, Issue 9 II, 1998, Pages 779-785

  Panje, R William ^a   Harrell, Erin ^a   Hier, Michael P ^a   Goldman, Andrew ^a   Garman, Guy R ^a   Bloch, Isac ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bleomycin; Electroporation; Head and neck cancer

Indexed keywords

BLEOMYCIN;

ADENOID CYSTIC CARCINOMA; ADULT; AGED; ARTICLE; CELL MEMBRANE PERMEABILITY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; ELECTROPORATION; FEMALE; HEAD AND NECK CANCER; HUMAN; MALE; MUSCLE SPASM; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SAFETY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR CLASSIFICATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; BLEOMYCIN; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; ELECTROPORATION; EQUIPMENT DESIGN; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MIDDLE AGED; NEOPLASM STAGING; OTORHINOLARYNGOLOGIC NEOPLASMS; SURVIVAL RATE;

EID: 0031659699     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348949810700908     Document Type: Article

References (22)

1. Orlowski S, Belehradek J Jr, Paoletti C, Mir LM. Transient electropermeabilization of cells in culture. Biochem Pharmacol 1988;37:4727-33.
2. Weaver JC. Electroporation: a general phenomenon for manipulating cells and tissues. J Cell Biochem 1993;51:426-35.
3. Mir LM, Orlowski S, Belehradek J Jr, Paoletti C. Electrochemotherapy: potentiation of anti-tumor effect of bleomycin by local electric pulses. Eur J Cancer 1991;27:68-72.
4. Okino M, Marumoto M, Kanesada H, Kuga H, Mohri H. Electrical impulse chemotherapy for rat solid tumors [Abstract]. Proc Jpn Cancer Congress 1987;46:420.
5. Okino M, Esato K. The effects of a single high voltage electrical stimulation with anticancer drug on in vivo growing malignant tumors. Jpn J Surg 1990;20:197-204.
6. Okino M, Tomie H, Kanesada H, et al. Induction of tumor specific selective toxicity in electrical impulse chemotherapy. Analysis of dose response curve. Oncologia 1991;24:71-9.
7. Okino M, Tomie H, Kanesada H, Marumoto M, Esato K, Suzuki H. Optimal electric conditions in electrical impulse chemotherapy. Jpn J Cancer Res 1992;83:1095-101.
8. Kanesada H. Anticancer effect of high voltage pulses combined with concentration dependent anticancer drugs on Lewis lung carcinoma. J Jpn Soc Cancer Ther 1990;25:2640-8.
9. Salford LG, Persson BRR, Brun A, Ceberg CP, Kongstad PCH, Mir LM. A new brain tumor therapy combining bleomycin with in vivo electropermeabilization. Biochem Biophys Res Commun 1993;194:938-43.
10. Heller R, Jaroszeski M, Leo-Messina J, et al. Treatment of B16 melanoma with the combination of electroporation and chemotherapy. Bioelectrochem Bioenerget 1995;36:83-7.
11. Sersa G, Cemazar M, Miklavcic D, Mir LM. Electrochemotherapy: variable antitumor effect on different tumor models. Bioelectrochem Bioenerget 1994;35:23-7.
12. Yamaguchi O, Irisawa C, Baba K, Ogihara M, Yokota T, Shiraiwa Y. Potentiation of antitumor effect of bleomycin by local electric pulses in mouse bladder tumor. Tohoku J Exp Med 1994;172:291-3.
13. Dev SB, Hofmann GA. Electrochemotherapy. A novel method of cancer treatment. Cancer Treat Rev 1994;20:105-15.
14. Mir LM, Belehradek M, Domenge C, et al. Electrochemo-therapy, a novel antitumor treatment: first clinical trial. CR Acad Sci Paris 1991;313:613-8.
15. Heller R, Jaroszeski MJ, Glass LF, et al. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer 1996;77:964-71.
16. Glass LF, Fenske NA, Jaroszeski M, et al. Bleomycin-mediated electrochemotherapy of basal cell carcinoma. J Am Acad Dermatol 1996;34:82-6.
17. Glass LF, Pepine ML, Fenske NA, Jaroszeski M, Reintgen DS, Heller R. Bleomycin-mediated electrochemotherapy of metastatic melanoma. Arch Dermatol 1996;132:1353-7.
18. Glass LF, Jaroszeski M, Gilbert R, Reintgen DS, Heller R. Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma. J Am Acad Dermatol 1997;39:596-9.
19. Hofmann GA, Dev SB, Nanda GS. Electrochemotherapy: transition from laboratory to the clinic. IEEE Eng Med Biol 1996;15:124-32.
20. Belehradek M, Domenge C, Luboinnski B, Orlowski S, Belehradek J, Mir LM. Electrochemotherapy, a new antitumor treatment. Cancer 1993;72:3694-700.
21. Panje WR. Regression of head and neck carcinoma with a prostaglandin synthesis inhibitor. Arch Otolaryngol 1981;107;658-63.
22. Mir LM, Orlowski S, Poddevin B, Belehradek J Jr. Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host's defenses. Eur Cytokine Netw 1992;3:331-4.